BioQL Invest ApS: Financial statements 2022
CVR: 37755001
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BioQL Invest ApS (CVR 37755001) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -7,500 and a net result of DKK 6,542,132 compared with DKK 6,547,044 the year before. Equity in the 2022 report amounted to DKK 6,651,705. The solvency ratio was 99.9%.
- Gross Profit
- DKK -7,500
- Profit/Loss
- DKK 6,542,132
- Equity
- DKK 6,651,705
- Total Assets
- DKK 6,659,205
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -8K | 6.5M | 6.7M | - |
| 2021 | - | -13K | 6.5M | 6.6M | - |
| 2020 | - | -299K | 15.8M | 7M | - |
| 2019 | - | -9K | -9K | 6.7M | - |
| 2018 | - | -3K | -3K | 6.8M | 0 |
Official annual report
Keep an eye on BioQL Invest ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BioQL Invest ApS has published its annual report for 2021. Gross profit came to DKK -12,500, and the net result was DKK 6,547,044.
About BioQL Invest ApS
BioQL Invest ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2016. The company is registered under the industry Investering for egen regning. The management consists of Mads Bredning Rydahl and Thomas Michael Redder Laursen. The company is owned by TMRL Holding ApS and Rydahl Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -9,737 and a net result of DKK -7,949 compared with DKK -4,372 the year before. Equity in the 2025 report amounted to DKK 70,917.